Data | Group A (No.=45) | Group B (No =30) | Group C (No=40) | Test of significance | P value |
---|---|---|---|---|---|
Clinico-demographic data | |||||
Sex | |||||
Male no. (%) | 24 (53.3) | 17 (56.7) | 20 (50) | χ2(0.03) | 0.95 |
Female no. (%) | 21 (46.7) | 13 (43.3) | 20 (50) | ||
Age(years) | |||||
Mean ± SD | 3.7 ± 2.89 | 3.9 ± 2.01 | 5.1 ± 3.95 | K (0.88) | 0.76 |
Range | 0.6-9.3 | 0.8-9.6 | 0.5– 10.3 | ||
Weight (Kg) | |||||
Mean ± SD | 8.35±3.9 | 8.5±3.8 | 9.8±4.7 | K (0.95) | 0.32 |
Height (cm) | |||||
Mean ± SD | 65.23 ± 15.9 | 70.8 ±16.2 | 72.2±22.4 | F (0.61) | 0.031* |
BMI (Kg/m2) | |||||
Mean ± SD | 13.1± 2.9 | 14.4±2.6 | 16.7±2.3 | F (0.60) | 0.032* |
HR | |||||
Mean ± SD | 127.5±17.1 | 81.4±9.3 | 70.3±6.7 | F (159.2) | ≤0.001* |
Post Hoc : P1=≤0.001, P2=≤0.001, P3=0.03 | |||||
RR | |||||
Mean ± SD | 46.5±13.4 | 37.5±6.5 | 35±7.1 | F (10.1) | ≤0.001* |
Post Hoc : P4≤0.001, P5=≤0.001, P6=0.36 | |||||
Systolic blood pressure | |||||
Mean ± SD | 93 ± 12.1 | 93.3 ±9.8 | 87±5.4 | F (2.9) | 0.06 |
Echo Findings | |||||
Ejection fraction % | |||||
Mean ± SD | 36.9±3.9 | 61.1±5.2 | NA | T (36.8) | ≤0.001* |
Range | 32.8 – 40.8 | 55.7 – 66.9 | |||
Fractional Shortening % | |||||
Mean ± SD | 23.3±4.1 | 42.4±3.2 | NA | T (20.1) | ≤0.001* |
Range | 18.8 – 28.5 | 37.6 – 45.1 | |||
LVEDD | |||||
Mean ± SD | 32.6± 11.1 | 29.1±3.1 | NA | T (1.68) | 0.0971 |
LVESD | |||||
Mean ± SD | 23.7± 6.7 | 13.7±2.3 | NA | T (7.85) | ≤0.001* |
laboratory investigations | |||||
Hb (gm/dl) | |||||
Mean ± SD | 10.1±1.4 | 9.9±1.4 | 10.1±1.3 | F ( 0.39) | 0.67 |
Leucocyte count /cm3 | |||||
Mean ± SD | 13.3± 3.9 | 13.7±3.7 | 7.4±3.7 | K (24.4) | ≤0.001* |
Platelet/cm3 | |||||
Mean ± SD | 240.6±62.2 | 236.7±61.2 | 236.4±59.2 | F (0.04) | 0.96 |
Serum creatinine | |||||
Mean ± SD | 0.59± 0.25 | 0.54±0.22 | 0.48±0.12 | K (0.42) | 0.0516 |
Galectin-3 (ng/dl) | |||||
Mean ± SD | 20.3±5.3 | 6.3±4.4 | 3.08±1.5 | K (50.7) | ≤0.001* |
Post Hoc: P7=≤0.001, P8=≤0.001, P9=0.01 |